Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cancer Patients' mental health under the microscope: new study tracks emotional toll

NCT ID NCT07168096

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 540 adults with solid cancers to see how their anxiety and depression levels change over six months. Participants fill out questionnaires about their mood, coping, and quality of life at the start, 3 months, and 6 months. No drugs or treatments are given—the goal is to learn what factors predict emotional distress so doctors can offer better support.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify which cancer patients are at higher risk for anxiety and depression, leading to better tailored mental health support.
What could go wrong
This is an observational study, not a treatment trial. It may not directly change patient outcomes, and results may not apply to all cancer types or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 540 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult oncology patients diagnosed with solid (non-hematologic) cancer at any stage, aged 18 years or older, who are candidates for perioperative systemic antineoplastic treatment or have advanced disease.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Histologically confirmed diagnosis of solid cancer (non-hematologic) at any stage. * Adult age (\>18 years). * Candidate for perioperative systemic antineoplastic treatment or for advanced disease. * Willingness to participate in the study and sign the informed consent form, as appropriate, before initiating any study-specific procedures, in accordance with good clinical practice requirements and local regulations. Exclusion Criteria: * Presence of a pre-existing psychiatric or neurodegenerative disorder that impairs the patient's ability to participate in the study. * Presence of reading and writing difficulties that prevent the patient from completing the assessments. * Receipt of oncological treatment in the past 2 years for another cancer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    18 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Complejo Hospitalario de Orense

    RECRUITING

    Ourense, Orense, 32005, Spain

  • Hospital General Universitario Morales Meseguer

    RECRUITING

    Murcia, Murcia, 30008, Spain

  • Hospital General Universitario Santa Lucía

    RECRUITING

    Cartagena, Murcia, 30202, Spain

  • Hospital General Universitario de Ciudad Real

    RECRUITING

    Ciudad Real, Ciudad Real, 13005, Spain

  • Hospital General Universitario de Elche

    RECRUITING

    Alicante, Elche, 03203, Spain

  • Hospital General Universitario de Valencia

    RECRUITING

    Valencia, Valencia, 46014, Spain

  • Hospital Universitario Central de Asturias

    RECRUITING

    Oviedo, Principality of Asturias, 33011, Spain

  • Hospital Universitario Fuenlabrada

    RECRUITING

    Fuenlabrada, Madrid, 28942, Spain

  • Hospital Universitario Infanta Leonor

    RECRUITING

    Vallecas, Madrid, 28031, Spain

  • Hospital Universitario Infanta Sofía

    RECRUITING

    San Sebastián de los Reyes, Madrid, 28702, Spain

  • Hospital Universitario La Paz

    RECRUITING

    Fuencarral-El Pardo, Madrid, 28046, Spain

  • Hospital Universitario Marqués de Valdecilla

    RECRUITING

    Santander, Cantabria, 39008, Spain

  • Hospital Universitario Miguel Servet

    RECRUITING

    Zaragoza, Zaragoza, 50009, Spain

  • Hospital Universitario Virgen de la Luz

    RECRUITING

    Cuenca, Cuenca, 16002, Spain

  • Hospital Universitario de Canarias

    RECRUITING

    Santa Cruz de Tenerife, Santa Cruz De Tenerife, 38320, Spain

  • Hospital Universitario de La Princesa

    RECRUITING

    Salamanca, Madrid, 28006, Spain

  • Hospital Universitario de Navarra

    RECRUITING

    Pamplona, Navarre, 31008, Spain

  • Hospital Universitario del Sureste

    RECRUITING

    Arganda, Madrid, 28500, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.